- Home
- TIGO vs NUVL Comparison
TIGO vs NUVL Comparison
Compare TIGO & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIGO
- NUVL
- Stock Information
- Founded
- TIGO 1990
- NUVL 2017
- Country
- TIGO Luxembourg
- NUVL United States
- Employees
- TIGO N/A
- NUVL N/A
- Industry
- TIGO Telecommunications Equipment
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- TIGO Telecommunications
- NUVL Health Care
- Exchange
- TIGO Nasdaq
- NUVL Nasdaq
- Market Cap
- TIGO 6.0B
- NUVL 5.5B
- IPO Year
- TIGO 1994
- NUVL 2021
- Fundamental
- Price
- TIGO $38.02
- NUVL $81.69
- Analyst Decision
- TIGO Buy
- NUVL Strong Buy
- Analyst Count
- TIGO 5
- NUVL 10
- Target Price
- TIGO $38.90
- NUVL $119.60
- AVG Volume (30 Days)
- TIGO 1.2M
- NUVL 556.6K
- Earning Date
- TIGO 08-07-2025
- NUVL 08-07-2025
- Dividend Yield
- TIGO 7.91%
- NUVL N/A
- EPS Growth
- TIGO 5635.24
- NUVL N/A
- EPS
- TIGO 2.06
- NUVL N/A
- Revenue
- TIGO $5,691,000,000.00
- NUVL N/A
- Revenue This Year
- TIGO N/A
- NUVL N/A
- Revenue Next Year
- TIGO $2.39
- NUVL N/A
- P/E Ratio
- TIGO $17.99
- NUVL N/A
- Revenue Growth
- TIGO N/A
- NUVL N/A
- 52 Week Low
- TIGO $23.61
- NUVL $55.54
- 52 Week High
- TIGO $38.92
- NUVL $113.51
- Technical
- Relative Strength Index (RSI)
- TIGO 58.64
- NUVL 60.10
- Support Level
- TIGO $36.59
- NUVL $78.94
- Resistance Level
- TIGO $38.92
- NUVL $82.45
- Average True Range (ATR)
- TIGO 0.92
- NUVL 2.76
- MACD
- TIGO -0.01
- NUVL 0.27
- Stochastic Oscillator
- TIGO 70.63
- NUVL 90.66
About TIGO Millicom International Cellular S.A.
Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia (100% owned), Nicaragua (100%), Panama (100%), El Salvador (100%), Guatemala (100%), Paraguay (100%), Colombia (50%), and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 120 million people, serving 42 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has agreed to sell the majority of its wireless towers to SBA Communications for $975 million.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.